|
nitric oxide donor
An agent, with unique chemical structure and biochemical requirements, which generates nitric oxide.
|
|
|
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes.
|
|
|
non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
|
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate
|
|
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid 4-nitrooxybutyl ester
|
ChemIDplus
|
|
AZD 3582
|
ChemIDplus
|
|
AZD3582
|
ChemIDplus
|
|
HCT 3012
|
ChemIDplus
|
|
Naproxen-N-butyl nitrate
|
ChemIDplus
|
|
Nitronaproxen
|
ChemIDplus
|
13(18(20)
